Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells
- Eur J Immunol. 2015 Oct;45(10):2911-7. doi: 10.1002/eji.201545523.
- 1. Institute of Molecular Medicine, University Hospital, University of Bonn, Bonn, Germany.
- 2. Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.
Inflammasome activation culminates in activation of Caspase-1, which leads to the maturation and subsequent release of cytokines of the interleukin 1 (IL-1) family and results in a particular form of cell death known as Pyroptosis. In addition, in the murine system, a so-called non-canonical inflammasome involving caspase-11 has been described that directly responds to cytosolic LPS. Here, we show that the human monocytic cell line THP1 activates the inflammasome in response to cytosolic LPS in a TLR4-independent fashion. This response is mediated by caspase-4 and accompanied by Caspase-1 activation, Pyroptosis, and IL-1β maturation. In addition to caspase-4, efficient IL-1β conversion upon intracellular LPS delivery relies on potassium efflux, NLRP3, ASC, and Caspase-1, indicating that although caspase-4 activation alone is sufficient to induce Pyroptosis, this process depends on the NLRP3 inflammasome activation to drive IL-1β maturation. Altogether, this study provides evidence for the presence of a non-canonical inflammasome in humans and its dependence on caspase-4.